Search
Search Results
##search.searchResults.foundPlural##
-
EPIDEMIOLOGICAL OVERVIEW OF HODGKIN LYMPHOMA ACROSS THE MEDITERRANEAN BASIN
3852PDF: 1309HTML: 5096Incidence age-standardized rates for HL across the Mediterranean basin: 259 -
Peripheral Red Blood Cell Split Chimerism as a Consequence of Intramedullary Selective Apoptosis of Recipient Red Blood Cells in a Case of Sickle Cell Disease
1765PDF: 1069HTML: 1897Untitled: 248Untitled: 225 -
HIV-ASSOCIATED VENOUS THROMBOEMBOLISM
4651PDF: 1565HTML: 8550 -
NOVEL DRUGS IN FOLLICULAR LYMPHOMA
5926PDF: 1608HTML: 1677Untitled: 283 -
CROCIN PROMOTES APOPTOSIS IN HUMAN EBV-TRANSFORMED B-LYMPHOCYTE VIA INTRINSIC PATHWAY CROCIN PROMOTES APOPTOSIS IN EBV-TRANSFORMED LCL
1435PDF: 577HTML: 306 -
SOLITARY PLASMACYTOMA
4275PDF: 2283HTML: 1422fIGURES 1,2: 279 -
-
REFRACTORY THROMBOCYTOPENIA AND NEUTROPENIA: A DIAGNOSTIC CHALLENGE
13001PDF: 1769HTML: 4366Cover letter: 268Figure 1: 279 -
IMATINIB IN CHRONIC MYELOID LEUKEMIA: AN OVERVIEW
5123PDF: 2983HTML: 2365 -
Guest Editor: Pellegrino Musto BISPECIFIC ANTIBODIES AND CAR T IN MULTIPLE MYELOMA: APPROPRIATE SELECTION OF PATIENTS AND SEQUENCING BISPECIFIC ANTIBODIES AND CAR T IN MULTIPLE MYELOMA
1840PDF: 1389HTML: 665 -
FIRST-PHASE INSULIN RESPONSE (FPIR) TO INTRAVENOUS GLUCOSE TOLERANCE TEST (IVGTT), INSULIN SENSITIVITY AND LONG-TERM FOLLOW-UP IN TRANSFUSION-DEPENDENT BETA-THALASSEMIA (TDT) NORMOGLYCEMIC PATIENTS WITH REDUCED INSULIN SECRETION TO ORAL GLUCOSE TOLERANCE TEST: A PILOT STUDY. The function of the endocrine pancreas in transfusion-dependent ?-thalassemia
7611PDF: 654HTML: 369 -
Guest Editor: G. Castaman AGING WITH HEMOPHILIA: THE CHALLENGE OF APPROPRIATE DRUG PRESCRIPTION Hemophilia and aging
3057PDF: 1525HTML: 332 -
NF- ?B Essential Modulator Deficiency Leading to Disseminated Cutaneous Atypical Mycobacteria
2229PDF: 1181HTML: 10765Untitled: 243 -
HHVs AND LYMPHOPROLIFERATIVE DISORDERS
1539PDF: 893HTML: 3147 -
TARGETING DORMANT BACILLI TO FIGHT TUBERCULOSIS
3211PDF: 1081HTML: 3233 -
The EVOLVING ROLE OF HAEMATOLOGY NURSING PRACTICE: A CROSS-SECTIONAL SURVEY
2209Suppl. Files: 966HTML: 603PDF: 841 -
IS HEMOGLOBIN E GENE WIDELY SPREAD IN THE STATE OF MADHYA PRADESH IN CENTRAL INDIA? EVIDENCE FROM FIVE TYPICAL FAMILIES
2700PDF: 944HTML: 8000Untitled: 236 -
LYON-UNIVERSITY HOSPITAL EXPERIENCE WITH GEMTUZUMAB OZOGAMICIN THERAPY IN ACUTE MYELOID LEUKEMIA: A ‘REAL-LIFE’ STUDY Gemtuzumab ozogamicin in AML
2010PDF: 1242HTML: 349 -
A Case of Rupioid Syphilis Masquerading as Aggressive Cutaneous Lymphoma
2792PDF: 1119HTML: 5128Cover Letter: 206Figure 2: 214Figure 1: 219Figure 3: 245Figure 4: 215Figure Legend: 232Table 1: 244Table 2: 229Table 3: 223 -
END-OF-LIFE CARE IN SICKLE CELL DISEASE AND TRASFUSION DEPENDEND-β-THALASSEMIA: CLINICAL, PSYCHOLOGICAL, AND ETHICAL CONSIDERATION Challenges in Supportive Care, Equity, and Compassion at End of Life
1268PDF: 887Html: 208 -
Flow Cytometry Method as a Diagnostic Tool for Pleural Fluid Involvement in a Patient with Multiple Myeloma
1566PDF: 788HTML: 4603Figure 1: Chest radiograph: 263Figure 2: Flow cytometer analysis of pleural fluid: 240 -
THE HEMATOLOGICAL PARAMETERS AND BIOCHEMICAL MARKERS OF IRON STATUS IN ALFA-THALASSEMIA 3.7KB DELETION FROM METROPOLITAN REGION OF MANAUS, AMAZONAS, BRAZIL. alfa-Thalassemia 3.7 deletion From Amazonas, Brazil.
4324PDF: 710HTML: 489 -
CHRONIC MYELOGENOUS LEUKEMIA (CML) IN THE ELDERLY
2994PDF: 1195HTML: 3085 -
Glucocorticoids and antivirals for HBV reactivation in onco-hematologic patients
1060PDF: 607HTML: 2231Cover Letter: 237 -
MOLECULAR PATHOGENESIS OF SECONDARY ACUTE PROMYELOCYTIC LEUKEMIA
3208PDF: 949HTML: 6621Untitled: 287Untitled: 246Untitled: 263Untitled: 268 -
Common variable immunodeficiency due to a novel NFKB1 variant in a child with thalassemia major CVID with thalassemia major
835PDF: 636HTML: 204 -
Improvement of liver involvement in familial Mediterranean fever after introduction of canakinumab: a case report Liver involvement in familial Mediterranean fever
1490PDF: 974HTML: 432 -
DOWNREGULATION OF STEAROYL-COA DESATURASE 1 (SCD-1) PROMOTES RESISTANCE TO IMATINIB IN CHRONIC MYELOID LEUKEMIA Downregulation of Scd-1 in Chronic Myeloid Leukemia
1553PDF: 1332HTML: 531







